Terms: = Breast cancer AND MYD88, Q99836, MYD88D, 4615 AND Treatment
27 results:
1. Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group.
Weng H; Shrestha PR; Hong H; Chen Z; Yu L; Yao Y; Zhang Z; Zou L; Zhu B; Zhou H; Liu X; Liu Y; Guo H; Huang H; Lin T
Cancer Med; 2023 Dec; 12(23):21188-21198. PubMed ID: 37997571
[TBL] [Abstract] [Full Text] [Related]
2. Baicalein prevents capecitabine-induced heart damage in female Wistar rats and enhances its anticancer potential in MCF-7 breast cancer cells.
Ibrahim HA; Abd El-Alim AEF; El-Hafeez MA; Metwally MMM; Khamis T; Galal AAA
Life Sci; 2023 Apr; 319():121523. PubMed ID: 36842762
[TBL] [Abstract] [Full Text] [Related]
3. Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies.
Bhujbal SP; He W; Hah JM
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234844
[TBL] [Abstract] [Full Text] [Related]
4. Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain.
Blazquez R; Chuang HN; Wenske B; Trigueros L; Wlochowitz D; Liguori R; Ferrazzi F; Regen T; Proescholdt MA; Rohde V; Riemenschneider MJ; Stadelmann C; Bleckmann A; Beißbarth T; van Rossum D; Hanisch UK; Pukrop T
Oncogene; 2022 Nov; 41(46):5008-5019. PubMed ID: 36224342
[TBL] [Abstract] [Full Text] [Related]
5. Curcumin ameliorates oxidized low-density lipoprotein (ox-LDL)-caused damage in human umbilical vein endothelial cells (HUVECs) through the miR-599/myd88/NF-κB axis.
Chen D; Zhu C; Ye S; Yang Q
Toxicol In Vitro; 2022 Dec; 85():105481. PubMed ID: 36156291
[TBL] [Abstract] [Full Text] [Related]
6. The cytotoxicity and apoptotic effects of verbascoside on breast cancer 4T1 cell line.
Daneshforouz A; Nazemi S; Gholami O; Kafami M; Amin B
BMC Pharmacol Toxicol; 2021 Nov; 22(1):72. PubMed ID: 34844644
[TBL] [Abstract] [Full Text] [Related]
7. NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative breast cancer Cells.
Quagliariello V; De Laurentiis M; Cocco S; Rea G; Bonelli A; Caronna A; Lombari MC; Conforti G; Berretta M; Botti G; Maurea N
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096896
[TBL] [Abstract] [Full Text] [Related]
8. Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008-2012.
Vogsen M; Bille C; Jylling AMB; Jensen MB; Ewertz M;
Acta Oncol; 2020 Jul; 59(7):741-747. PubMed ID: 32364416
[No Abstract] [Full Text] [Related]
9. Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in breast cancer Cells.
Güney Eskiler G; Deveci Özkan A; Kaleli S; Bilir C
J Pharm Pharm Sci; 2019; 22(1):281-291. PubMed ID: 31287789
[TBL] [Abstract] [Full Text] [Related]
10. TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition.
Zandi Z; Kashani B; Poursani EM; Bashash D; Kabuli M; Momeny M; Mousavi-Pak SH; Sheikhsaran F; Alimoghaddam K; Mousavi SA; Ghaffari SH
Eur J Pharmacol; 2019 Jun; 853():256-263. PubMed ID: 30930249
[TBL] [Abstract] [Full Text] [Related]
11. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of myd88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract] [Full Text] [Related]
12. TLR4/myd88 signaling determines the metastatic potential of breast cancer cells.
Wu K; Zhang H; Fu Y; Zhu Y; Kong L; Chen L; Zhao F; Yu L; Chen X
Mol Med Rep; 2018 Sep; 18(3):3411-3420. PubMed ID: 30066873
[TBL] [Abstract] [Full Text] [Related]
13. Ethanol extract of propolis and its constituent caffeic acid phenethyl ester inhibit breast cancer cells proliferation in inflammatory microenvironment by inhibiting TLR4 signal pathway and inducing apoptosis and autophagy.
Chang H; Wang Y; Yin X; Liu X; Xuan H
BMC Complement Altern Med; 2017 Sep; 17(1):471. PubMed ID: 28950845
[TBL] [Abstract] [Full Text] [Related]
14. Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance.
Edwardson DW; Boudreau J; Mapletoft J; Lanner C; Kovala AT; Parissenti AM
PLoS One; 2017; 12(9):e0183662. PubMed ID: 28915246
[TBL] [Abstract] [Full Text] [Related]
15. Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative breast cancer: A Useful Cell Model System for Drug Screening.
Christensen AG; Ehmsen S; Terp MG; Batra R; Alcaraz N; Baumbach J; Noer JB; Moreira J; Leth-Larsen R; Larsen MR; Ditzel HJ
Stem Cells; 2017 Aug; 35(8):1898-1912. PubMed ID: 28600813
[TBL] [Abstract] [Full Text] [Related]
16. Increased expression of myd88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.
Ma FJ; Liu ZB; Hu X; Ling H; Li S; Wu J; Shao ZM
PLoS One; 2014; 9(10):e111639. PubMed ID: 25360699
[TBL] [Abstract] [Full Text] [Related]
18. Lower expression of Nrdp1 in human glioma contributes tumor progression by reducing apoptosis.
Shi H; Du J; Wang L; Zheng B; Gong H; Wu Y; Tang Y; Gao Y; Yu R
IUBMB Life; 2014 Oct; 66(10):704-10. PubMed ID: 25355637
[TBL] [Abstract] [Full Text] [Related]
19. MAP1S controls breast cancer cell TLR5 signaling pathway and promotes TLR5 signaling-based tumor suppression.
Shi M; Yao Y; Han F; Li Y; Li Y
PLoS One; 2014; 9(1):e86839. PubMed ID: 24466264
[TBL] [Abstract] [Full Text] [Related]
20. Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.
Simonsson M; Söderlind V; Henningson M; Hjertberg M; Rose C; Ingvar C; Jernström H
Cancer Causes Control; 2013 May; 24(5):929-40. PubMed ID: 23412805
[TBL] [Abstract] [Full Text] [Related]
[Next]
